{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:33:57Z","timestamp":1747172037261,"version":"3.40.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.urology.2014.02.014","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T16:04:31Z","timestamp":1397405071000},"page":"1339-1343","source":"Crossref","is-referenced-by-count":5,"title":["Practice Patterns of Urologists in Managing Korean Men Aged 40\u00a0Years or Younger With High Serum Prostate-specific Antigen Levels"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-1324","authenticated-orcid":false,"given":"Dae-Seon","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hyo","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Ho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Yul","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hyub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hyun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2014.02.014_bib1","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.02.014_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2006.07.012","article-title":"Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer\u2014results from a prospective, population-based randomized controlled trial","volume":"51","author":"Aus","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1470-2045(10)70146-7","article-title":"Mortality results from the Goteborg randomised population-based prostate-cancer screening trial","volume":"11","author":"Hugosson","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2014.02.014_bib4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","article-title":"Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends","volume":"94","author":"Etzioni","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.urology.2014.02.014_bib5","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.bjc.6605422","article-title":"Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer","volume":"101","author":"Heijnsdijk","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2014.02.014_bib6","first-page":"2232","article-title":"Prostate specific antigen best practice statement: 2009 update","volume":"182","author":"Greene","year":"2009","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib7","first-page":"419","article-title":"Early detection of prostate cancer: AUA guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.canep.2009.07.010","article-title":"Prostate-specific antigen screening of workers under the age of 40 in Japan","volume":"33","author":"Kawada","year":"2009","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.urology.2014.02.014_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/bju.12354","article-title":"Population based analysis of prostate specific antigen (PSA) screening in younger men (<55 years) in Australia","volume":"113","author":"Ranasinghe","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.02.014_bib10","first-page":"2189","article-title":"Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland","volume":"166","author":"Hakama","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease","volume":"59","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.6004\/jnccn.2010.0016","article-title":"NCCN clinical practice guidelines in oncology: prostate cancer early detection","volume":"8","author":"Kawachi","year":"2010","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.urology.2014.02.014_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.urology.2011.02.061","article-title":"Variable prostate-specific antigen management patterns by nonurologist providers at a tertiary care medical center","volume":"78","author":"Lin","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2014.02.014_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.med.57.011205.135654","article-title":"Prostatitis\/chronic pelvic pain syndrome","volume":"57","author":"Habermacher","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.urology.2014.02.014_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncpuro0702","article-title":"The responsible use of antibiotics for an elevated PSA level","volume":"4","author":"Scardino","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/bju.12241","article-title":"Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial","volume":"112","author":"Eggener","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.02.014_bib17","doi-asserted-by":"crossref","first-page":"691380","DOI":"10.1155\/2012\/691380","article-title":"Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007","volume":"2012","author":"Li","year":"2012","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.urology.2014.02.014_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4111\/kju.2010.51.1.21","article-title":"Outcome of prostate biopsy in men younger than 40 years of age with high prostate-specific antigen (PSA) levels","volume":"51","author":"Yang","year":"2010","journal-title":"Korean J Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib19","first-page":"2179","article-title":"Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers","volume":"157","author":"Ornstein","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0094-0143(05)70375-X","article-title":"The effects of prostatic manipulation on prostate-specific antigen levels","volume":"24","author":"Klein","year":"1997","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2014.02.014_bib21","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/jnci\/djn362","article-title":"The influence of statin medications on prostate-specific antigen levels","volume":"100","author":"Hamilton","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.urology.2014.02.014_bib22","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.298.19.2275","article-title":"Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer","volume":"298","author":"Banez","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2014.02.014_bib23","first-page":"1959","article-title":"Prostate specific antigen assay standardization bias could affect clinical decision making","volume":"180","author":"Loeb","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.eururo.2012.07.029","article-title":"A\u00a0calculator for prostate cancer risk 4 years after an initially negative screen: findings from ERSPC Rotterdam","volume":"63","author":"Roobol","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00345-012-0869-2","article-title":"Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group","volume":"32","author":"Ankerst","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib26","first-page":"529","article-title":"Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy","volume":"183","author":"Nguyen","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2008.05.022","article-title":"The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review","volume":"54","author":"Schroder","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.urology.2014.02.014_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.eururo.2009.08.025","article-title":"A\u00a0risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer","volume":"57","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.02.014_bib30","first-page":"1792","article-title":"Evidence supports a faster growth rate and\/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity","volume":"183","author":"Powell","year":"2010","journal-title":"J\u00a0Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514001708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514001708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T21:49:59Z","timestamp":1716673799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429514001708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0090429514001708"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2014.02.014","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}